Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 12 | 2024 | 5146 | 1.130 |
Why?
|
Alternative Splicing | 1 | 2022 | 1093 | 0.580 |
Why?
|
Optical Fibers | 1 | 2015 | 135 | 0.490 |
Why?
|
Receptors, Immunologic | 1 | 2021 | 1410 | 0.490 |
Why?
|
Bone Marrow | 2 | 2021 | 2911 | 0.390 |
Why?
|
Endocrine System Diseases | 1 | 2014 | 249 | 0.390 |
Why?
|
beta-Thalassemia | 1 | 2014 | 236 | 0.390 |
Why?
|
DNA Copy Number Variations | 2 | 2021 | 2020 | 0.370 |
Why?
|
Pelvis | 1 | 2015 | 733 | 0.370 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4415 | 0.310 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 2915 | 0.290 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2693 | 0.270 |
Why?
|
B-Cell Maturation Antigen | 2 | 2023 | 149 | 0.220 |
Why?
|
Nuclear Factor 45 Protein | 1 | 2017 | 5 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2024 | 5305 | 0.150 |
Why?
|
Macrolides | 1 | 2018 | 205 | 0.140 |
Why?
|
beta-Lactams | 1 | 2018 | 155 | 0.140 |
Why?
|
Exons | 1 | 2022 | 2391 | 0.140 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1526 | 0.140 |
Why?
|
Fluoroquinolones | 1 | 2018 | 307 | 0.130 |
Why?
|
Cytochromes b | 1 | 2014 | 35 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1469 | 0.120 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 53 | 0.120 |
Why?
|
Gonadal Disorders | 1 | 2014 | 5 | 0.120 |
Why?
|
Sulfonamides | 1 | 2024 | 1978 | 0.120 |
Why?
|
Community-Acquired Infections | 1 | 2018 | 469 | 0.120 |
Why?
|
Nitrous Oxide | 1 | 2015 | 166 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2021 | 2417 | 0.110 |
Why?
|
Spectrum Analysis | 1 | 2015 | 453 | 0.110 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11122 | 0.100 |
Why?
|
RNA Splicing | 1 | 2017 | 918 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2021 | 1073 | 0.100 |
Why?
|
Reference Standards | 1 | 2015 | 1003 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2020 | 1600 | 0.100 |
Why?
|
Homocysteine | 1 | 2015 | 638 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 3877 | 0.090 |
Why?
|
Anesthetics, Inhalation | 1 | 2015 | 574 | 0.080 |
Why?
|
Alleles | 1 | 2021 | 6864 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4652 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2021 | 3548 | 0.080 |
Why?
|
ROC Curve | 1 | 2015 | 3579 | 0.070 |
Why?
|
Anesthesia, General | 1 | 2015 | 1174 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3816 | 0.070 |
Why?
|
Pneumonia | 1 | 2018 | 2143 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 1935 | 0.070 |
Why?
|
Turkey | 2 | 2018 | 254 | 0.070 |
Why?
|
Humans | 17 | 2024 | 761572 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6426 | 0.060 |
Why?
|
Dexamethasone | 2 | 2023 | 1948 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11742 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2472 | 0.050 |
Why?
|
Melphalan | 1 | 2023 | 420 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13642 | 0.050 |
Why?
|
Bone Density | 1 | 2014 | 3551 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2014 | 3963 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7407 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4235 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 266 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 380 | 0.040 |
Why?
|
Hospital Departments | 1 | 2018 | 134 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2023 | 2115 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 1406 | 0.040 |
Why?
|
Mice | 2 | 2023 | 81533 | 0.040 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2017 | 41 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 16986 | 0.040 |
Why?
|
Age Factors | 1 | 2014 | 18398 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 517 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2021 | 1393 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2020 | 1745 | 0.030 |
Why?
|
Male | 7 | 2020 | 360842 | 0.030 |
Why?
|
Streptococcus pneumoniae | 1 | 2018 | 730 | 0.030 |
Why?
|
Consanguinity | 1 | 2014 | 456 | 0.030 |
Why?
|
Animals | 2 | 2023 | 168467 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4111 | 0.020 |
Why?
|
Chromatin | 1 | 2023 | 2961 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2018 | 1277 | 0.020 |
Why?
|
Living Donors | 1 | 2015 | 641 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2020 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1814 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6132 | 0.020 |
Why?
|
Child | 2 | 2014 | 80156 | 0.020 |
Why?
|
Adolescent | 2 | 2014 | 88324 | 0.020 |
Why?
|
Female | 6 | 2020 | 392686 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8528 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6312 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9319 | 0.020 |
Why?
|
DNA Repair | 1 | 2017 | 2046 | 0.020 |
Why?
|
Folic Acid | 1 | 2015 | 1323 | 0.020 |
Why?
|
DNA Damage | 1 | 2017 | 2449 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10448 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2023 | 8552 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12725 | 0.020 |
Why?
|
Hospitals | 1 | 2018 | 3882 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9280 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2018 | 5293 | 0.010 |
Why?
|
Middle Aged | 4 | 2020 | 220920 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7858 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 64684 | 0.010 |
Why?
|
Prospective Studies | 2 | 2018 | 54426 | 0.010 |
Why?
|
Aged | 3 | 2020 | 169310 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12341 | 0.010 |
Why?
|
Adult | 3 | 2020 | 221203 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14607 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 30054 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58986 | 0.010 |
Why?
|
Concepts
(105)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_